Le Lézard16m
Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer's disease
Alpha Cognition Inc. ("Alpha Cognition" (ACI), or the "Company"), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that the ...
Abbvie And Xilio Therapeutics Announce Collaboration And Option Agreement To Develop Novel Tumor-Activated Immunotherapies
Collaboration will combine AbbVie's oncology expertise and Xilio's proprietary tumor-activation technology to develop novel immunotherapi ...